Novartis Investigative Site

Barsinghausen 30890

0 studies enrolling now · 4 studies all time

What they study most

Cardiovascular Disease, Heart Failure With Reduced Ejection Fraction, Relapsing Multiple Sclerosis, Type 2 Diabetes Mellitus

Studies at this site

• Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS — Running, not enrolling
• Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis — Completed
• This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure — Stopped early
• Aliskiren Trial in Type 2 Diabetes Using Cardiovascular and Renal Disease Endpoints (Core and Extension Phases) — Stopped early